New hope for lupus patients: drug trial targets kidney damage
Disease control
Recruiting now
This study tests a new drug called cenerimod for people with lupus who have active kidney inflammation (lupus nephritis). About 300 adults will take either cenerimod or a placebo daily for 76 weeks, on top of their usual treatments. The goal is to see if cenerimod can improve kid…
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated May 14, 2026 12:06 UTC